… patients staged as intermediate HCC (Barcelona Clinic Liver Cancer stage B). If applied
correctly, TACE can produce survival benefits … group of patients, not all of whom will benefit from …

… gefitinib failure requires optimal patient selection to obtain clinical benefits in relapsed non-…
to determine which clinical factors best identify patients who benefit from erlotinib therapy. …

… for limited clinical benefit.2 In order to maximize safety in this vulnerable patient population
… The judiciousness of these criteria in guiding the selection of patients for phase 1 trials has …

… The SPRINT clinical benefit models can efficiently prioritize intensive treatment to first …
benefit patients before offering intensive treatment to the remainder of SPRINT-eligible patients. …

… clinical outcome after drug-eluting stents (DES) implantation, and to test if patient selection
could enhance their net clinical benefit… that may help selecting patients who are candidates to …

… Large clinical trials have demonstrated morbidity and mortality benefits of CRT in patients …
Despite the documented benefits, 20–30% of patients selected to have CRT do not respond …

… , and it remains possible that viability testing may be a modality to help in this selection. …
add value in patient selection for surgical revascularization. Among the 1212 patients enrolled in …

… clinical trial (RCT) data have not shown a benefit of PCI over MED in nonfatal events [24,
25, 26, 27]. For patients in … The ongoing Clinical Outcomes Utilizing Percutaneous Coronary …

… : already disadvantaged patients may not benefit from the high-volume effect; and patients
… Clinical details that may influence patient outcomes or reasons for referral are not available. …

… and physician, ranging from “I prefer to make the final selection about which treatment I
will receive” (option A), to “I prefer that my doctor and I share responsibility for deciding which …